You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC. (D.N.J. 2018)

✉ Email this page to a colleague

« Back to Dashboard

CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC. (D.N.J. 2018)

Docket	⤷ Sign Up	Date Filed	2018-06-19
Court	District Court, D. New Jersey	Date Terminated	2019-05-13
Cause	15:1126 Patent Infringement	Assigned To	Esther Salas
Jury Demand	None	Referred To	Michael A. Hammer
Parties	ALVOGEN PINE BROOK, LLC
Patents	6,281,230; 6,476,052; 6,555,554; 7,393,862; 7,968,569; 8,198,262; 8,673,939; 8,735,428; 8,828,427; 9,993,467
Attorneys	AARON SCOTT ECKENTHAL
Firms	Saul Ewing Arnstein & Lehr LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Biologic Drugs cited in CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC.

The biologic drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for CELGENE CORPORATION v. SYNTHON PHARMECEUTICALS, INC. (D.N.J. 2018)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-06-19	1	Complaint	Corporation, Summit, NJ (US) 6,281,230 B1 8/2001 Muller eta!. … a patient in need of such treatment or pre- 6,281,230 and 6,316,471, both to G. W. Muller, eta!. … such as those described in U.S. Pat. Nos. 6,281,230 and proteins and antibodies), examples of which… Pat. Nos. 6,281,230; 6,316,471; 6,335,349; and 6,476,052, compounds…antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/	External link to document
2018-11-19	24	Amended Complaint	Corporation, Summit, NJ (US) 6,281,230 B1 8/2001 Muller eta!. …a patient in need of such treatment or pre- 6,281,230 and 6,316,471, both to G. W. Muller, eta!. … such as those described in U.S. Pat. Nos. 6,281,230 and proteins and antibodies), examples of which… Pat. Nos. 6,281,230; 6,316,471; 6,335,349; and 6,476,052, compounds…antibiotics, collagen, botulinum toxin, inter- Nos. 6,281,230 and 5,635,517; U.S. publication nos. 2004/	External link to document
2019-05-09	50	Letter	Consent Judgment, the term “Patents-in-Suit” shall mean U.S. Patent Nos. 8,198,262; 8,673,939; 8,735,428; … 4. Until expiration of the Patents-in-Suit, Synthon, including any of its successors…successors and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through any third …parties in connection with any infringement of the Patents-in-Suit by any such third parties in connection… 21 C.F.R. § 314.94(a)(12) with respect to the Patents-in-Suit. 9. Nothing herein	External link to document
2019-05-13	52		Judgment, the term “Patents-in-Suit” shall mean U.S. Patent Nos. 8.198,262; 8,673,939; 8.735.428: 8.828.427…10,093,648: and 10,093,649, 4. Until expiration of the Patents-in-Suit. Synthon, including any of its successors…successors and assigns, is enjoined from infringing the Patents-in-Suit, on its own part or through any third party…parties in connection with any infringement of the Patents-in-Suit by any such third parties in connection…21 C.F.R. §$ 314.94(a)(12) with respect to the Patents-in-Suit. 9, Nothing herein restricts or is intended	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.